Saudi Arabia
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
35.80%
|
Dec. 31, 2023 | USD 21.03 | -0.22% |
|
Saudi Arabia |
|
2 |
18.86%
|
Dec. 31, 2023 | USD 31.63 | -0.05% |
|
Saudi Arabia |
|
3 |
14.36%
|
Dec. 31, 2023 | USD 20.64 | -0.86% |
|
Saudi Arabia |
|
4 |
10.52%
|
Dec. 31, 2023 | USD 8.71 | -0.52% |
|
Saudi Arabia |
|
5 |
8.27%
|
Dec. 31, 2023 | USD 13.98 | -4.75% |
|
Saudi Arabia |
The Drugstores & Retail Pharmacies company in Saudi Arabia with the highest EBITDA Margin is Naba Alsaha Medical Services Company (Saudi Stock Exchange: 9546.SR) at 35.80%.
The Drugstores & Retail Pharmacies company in Saudi Arabia with the lowest EBITDA Margin is Al-Razi Medical Co. (Saudi Stock Exchange: 9572.SR) at 8.27%.
The top 10 Drugstores & Retail Pharmacies companies in Saudi Arabia by EBITDA Margin are Naba Alsaha Medical Services Company, Nahdi Medical Company, Al-Dawaa Medical Services Company, Saudi Pharmaceutical Industries and Medical Appliances Corporation and Al-Razi Medical Co..
The bottom 10 Drugstores & Retail Pharmacies companies in Saudi Arabia by EBITDA Margin are Al-Razi Medical Co., Saudi Pharmaceutical Industries and Medical Appliances Corporation, Al-Dawaa Medical Services Company, Nahdi Medical Company and Naba Alsaha Medical Services Company.